Already in preclinical models, the consequences of diabetes such as inflammation, hyperglycemia, hyperinsulinemia and increased levels of insulin-like growth factor 1 (IGF-1) have been shown to promote tumor growth (7–9). This evidence concerns the gene IGF1 and neoplasm.